Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

American BioScience Licenses Japanese Rights To Abraxane

Nov. 17, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Gilead: Five-Year Hepsera Data Show Continued Efficacy In HBV

Nov. 16, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Nov. 15, 2005

By Jennifer Boggs

Aphton Ends Sanofi Deal, Seeks New Insegia Partner

Nov. 11, 2005

By Jennifer Boggs

PTC Raises $26M Privately; Lead Drug To Start Phase II

Nov. 11, 2005

By Jennifer Boggs

Aphton Ends Sanofi Deal, Seeks New Insegia Partner

Nov. 11, 2005

By Jennifer Boggs

PTC Raises $26M Privately; Lead Drug To Start Phase II

Nov. 11, 2005

By Jennifer Boggs

Versant Closes $400M Fund, Seeks Early Stage Companies

Nov. 10, 2005

By Jennifer Boggs

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 6, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...